Future research should focus on the specific interactions of chemerin in individuals with a normal weight and T2D, the secretion dynamics of chemerin relative to other adipokines, and whether isoform-specific expression can discriminate between T2D in individuals with a normal weight and those with obesity. Here, RARRES2 is linked to type 2 diabetes mellitus.